Wells Fargo Maintains Equal-Weight on Oscar Health, Raises Price Target to $27
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and raises the price target from $20 to $27.
Read original at benzingaStocks · News reference
Oscar Health Raises Outlook But Warns CMS Membership Churn Will Pick Up
Oscar Health (OSCR) beat Q2 earnings with $4.88B revenue, but shares fell on expected ACA membership churn in H2. Read more.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 4:31 PM
- Checked
- Aug 6, 2026, 4:31 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
UBS Maintains Neutral on Oscar Health, Raises Price Target to $26
UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $20 to $26.
Read original at benzingaBarclays Maintains Overweight on Oscar Health, Raises Price Target to $39
Read original at benzinga